Thu, 05/07/2009 - 18:56
China to reap benefits of drug R & D investment in near future - Certara COO
by Karl Zhong
Patrick Flanagan, chief operating officer of Certara, a leading pharmaceuticals solution company, recently spoke to Interfax about his views on China's new drug research and development strategy and specifically, the company's priorities in China.
Certara considers China a key strategic market.
- Patrick Flanagan, chief operating officer of Certara
Shanghai. May 7. INTERFAX-CHINA - The Chinese government's investment in new drug research and development will likely produce robust results within a short period of time, according to Patrick Flanagan, chief operating officer of Certara, a U.S.-based leading provider of drug discovery and development informatics products and services.
